XML 37 R25.htm IDEA: XBRL DOCUMENT v3.25.1

INVESTMENTS (Tables)

3 Months Ended

Mar. 31, 2025

Investments, All Other Investments [Abstract]

Schedule of Cash and Financial Assets Measured at Fair Value on a Recurring Basis

The following tables present the Company’s cash and financial assets that are measured at fair value on a recurring basis for each of the hierarchy levels (in thousands):

			March 31, 2025
			Cost						Unrealized Gains (Losses)						Accrued Interest						Estimated Fair Value						Cash & Cash Equivalents						Investment Securities
Cash and cash equivalents, excluding money market accounts			$	78,246					$	—					$	—					$	78,246					$	78,246					$	—
Level 1:
Money market accounts			13,471						—						—						13,471						13,471						—
Government & agency securities			29,060						47						118						29,225						—						29,225
Equity securities			10,000						(3,339)						—						6,661						—						6,661
			52,531						(3,292)						118						49,357						13,471						35,886
Level 2:
Corporate bonds			36,360						274						356						36,990						—						36,990
Total			$	167,137					$	(3,018)					$	474					$	164,593					$	91,717					$	72,876

			December 31, 2024
			Cost						Unrealized Gains (Losses						Accrued Interest						Estimated Fair Value						Cash & Cash Equivalents						Investment Securities
Cash and cash equivalents, excluding money market accounts			$	77,551					$	—					$	—					$	77,551					$	77,551					$	—
Level 1:
Money market accounts			13,377						—						—						13,377						13,377						—
Government & agency securities			28,920						15						96						29,031						—						29,031
Equity securities			10,000						(3,939)						—						6,061						—						6,061
			52,297						(3,924)						96						48,469						13,377						35,092
Level 2:
Corporate bonds			35,771						227						326						36,324						—						36,324
Total			$	165,619					$	(3,697)					$	422					$	162,344					$	90,928					$	71,416

Summary of Investment Gains

The gains related to the Company’s LifeMD investment for the three months ended March 31, 2025 and 2024 are summarized in the table below (in thousands):

			March 31, 2025						March 31, 2024
Net gains recognized during the period on equity securities			$	600					$	2,437
Less: Net gains recognized on equity securities sold			—						—
Unrealized gains recognized during the reporting period on equity securities still held at the reporting date			$	600					$	2,437

X

- Definition

Tabular disclosure of realized and unrealized gain (loss) on investment in security.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(9)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(7)(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

+ Details

Name:	us-gaap_GainLossOnInvestmentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_InvestmentsAllOtherInvestmentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration